Full Press Release Details
[et_pb_section fb_built=”1″ _builder_version=”4.16″ custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_post_title author=”off” categories=”off” comments=”off” admin_label=”15th Annual World ADC Conference – Presentation” _builder_version=”4.23.4″ title_level=”h2″ title_text_color=”#0c71c3″ title_font_size=”28px” title_letter_spacing=”1px” title_line_height=”1.4em” meta_text_color=”#000000″ global_colors_info=”{}”][/et_pb_post_title][et_pb_divider color=”#0badbc” divider_weight=”2px” _builder_version=”4.16″ global_colors_info=”{}”][/et_pb_divider][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font_size=”19px” global_colors_info=”{}”]
STRO-004, a Next-Generation Tissue Factor (TF)-Targeted DAR8-Exatecan ADC, Demonstrates Superior Efficacy Across TF-Expressing Solid Tumors in a Comprehensive Single-Mouse PDX Trial
Presenter: Genevive Hernandez, Ph.D.
[/et_pb_text][et_pb_button button_url=”https://www.sutrobio.com/wp-content/uploads/2026/04/STRO-004_AACR2026_GH_19apr2026.pdf” url_new_window=”on” button_text=”Presentation” button_alignment=”left” admin_label=”Presentation – Button” _builder_version=”4.27.4″ _module_preset=”default” custom_button=”on” button_text_size=”18px” button_text_color=”#0C71C3″ button_bg_color=”#FFFFFF” button_border_width=”1px” button_border_color=”#0C71C3″ button_border_radius=”3px” button_icon=”||divi||400″ button_icon_color=”#0C71C3″ button_on_hover=”off” global_colors_info=”{}”][/et_pb_button][et_pb_gallery gallery_ids=”17826,17827,17828,17829,17830,17831,17832,17833,17834,17835,17836,17837,17838,17839,17840,17841,17842,17843,17844,17845″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” pagination_text_color=”#FFFFFF” module_alignment=”center” global_colors_info=”{}”][/et_pb_gallery][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font_size=”19px” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]
Phase 1 open-label study to evaluate safety, pharmacokinetics, and preliminary anti-tumor activity of STRO-004 in adults with refractory/recurrent metastatic solid tumors
Presenter: Jennifer Oliver, MD
[/et_pb_text][et_pb_button button_url=”https://www.sutrobio.com/wp-content/uploads/2026/04/Sutro_AACR-2026_-STRO-004-STI-TiP-V4_Final.pdf” url_new_window=”on” button_text=”Presentation” button_alignment=”left” admin_label=”Presentation – Button” _builder_version=”4.27.4″ _module_preset=”default” custom_button=”on” button_text_size=”18px” button_text_color=”#0C71C3″ button_bg_color=”#FFFFFF” button_border_width=”1px” button_border_color=”#0C71C3″ button_border_radius=”3px” button_icon=”||divi||400″ button_icon_color=”#0C71C3″ button_on_hover=”off” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_button][et_pb_gallery gallery_ids=”17853″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” pagination_text_color=”#FFFFFF” module_alignment=”center” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_gallery][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font_size=”19px” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]
STRO-006: An Integrin beta-6–targeting ADC demonstrates favorable safety profile and potent antitumor activity in preclinical solid tumors
Presenter: Kshama Doshi, Ph.D.
[/et_pb_text][et_pb_button button_url=”https://www.sutrobio.com/wp-content/uploads/2026/04/AACR-2026_STRO-006-Poster_Final.pdf” url_new_window=”on” button_text=”Presentation” button_alignment=”left” admin_label=”Presentation – Button” _builder_version=”4.27.4″ _module_preset=”default” custom_button=”on” button_text_size=”18px” button_text_color=”#0C71C3″ button_bg_color=”#FFFFFF” button_border_width=”1px” button_border_color=”#0C71C3″ button_border_radius=”3px” button_icon=”||divi||400″ button_icon_color=”#0C71C3″ button_on_hover=”off” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_button][et_pb_gallery gallery_ids=”17858″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” pagination_text_color=”#FFFFFF” module_alignment=”center” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_gallery][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font_size=”19px” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]
Preclinical characterization of STRO-227: A PTK7-targeting dual-payload ADC with topoisomerase 1 and tubulin inhibitors
Presenter: Daniel Calarese, Ph.D.
[/et_pb_text][et_pb_button button_url=”https://www.sutrobio.com/wp-content/uploads/2026/04/2025-AACR-STRO-227-Poster-Final-54×31.5-1.pdf” url_new_window=”on” button_text=”Presentation” button_alignment=”left” admin_label=”Presentation – Button” _builder_version=”4.27.4″ _module_preset=”default” custom_button=”on” button_text_size=”18px” button_text_color=”#0C71C3″ button_bg_color=”#FFFFFF” button_border_width=”1px” button_border_color=”#0C71C3″ button_border_radius=”3px” button_icon=”||divi||400″ button_icon_color=”#0C71C3″ button_on_hover=”off” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_button][et_pb_gallery gallery_ids=”17859″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” pagination_text_color=”#FFFFFF” module_alignment=”center” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_gallery][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font_size=”19px” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]
The HER2-targeting dual-payload antibody-drug conjugate combining a topoisomerase I inhibitor and a microtubule inhibitor demonstrates superior efficacy and overcomes resistance to single-payload ADCs in xenograft models
Presenter: Angela Matcham, Ph.D.
[/et_pb_text][et_pb_button button_url=”https://www.sutrobio.com/wp-content/uploads/2026/04/Matcham_AACRPoster1685_aHER2dpADC_Final.pdf” url_new_window=”on” button_text=”Presentation” button_alignment=”left” admin_label=”Presentation – Button” _builder_version=”4.27.4″ _module_preset=”default” custom_button=”on” button_text_size=”18px” button_text_color=”#0C71C3″ button_bg_color=”#FFFFFF” button_border_width=”1px” button_border_color=”#0C71C3″ button_border_radius=”3px” button_icon=”||divi||400″ button_icon_color=”#0C71C3″ button_on_hover=”off” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_button][et_pb_gallery gallery_ids=”17857″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” pagination_text_color=”#FFFFFF” module_alignment=”center” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_gallery][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font_size=”19px” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]
Sutro’s Site-Specific Dual-Payload ADCs Combining TOPO1i and DNA Damage Response Inhibitors to Enhance Efficacy, Overcome Resistance, and Improve Safety
Presenter: Krishna Bajjuri, Ph.D.
[/et_pb_text][et_pb_button button_url=”https://www.sutrobio.com/wp-content/uploads/2026/04/Sutro-AACR26-TOPO1i-x-DDRi-dpADC-final-poster-040226.pdf” url_new_window=”on” button_text=”Presentation” button_alignment=”left” admin_label=”Presentation – Button” _builder_version=”4.27.4″ _module_preset=”default” custom_button=”on” button_text_size=”18px” button_text_color=”#0C71C3″ button_bg_color=”#FFFFFF” button_border_width=”1px” button_border_color=”#0C71C3″ button_border_radius=”3px” button_icon=”||divi||400″ button_icon_color=”#0C71C3″ button_on_hover=”off” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_button][et_pb_gallery gallery_ids=”17854″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” pagination_text_color=”#FFFFFF” module_alignment=”center” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_gallery][/et_pb_column][/et_pb_row][/et_pb_section]